9
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Cytotoxicity of antineoplastic agents on rabbit corneal epithelium in vitro

, , &
Pages 79-87 | Published online: 27 Sep 2008
 

Abstract

We studied the cytotoxic effects of antineoplastic agents in vitro including cytosine arabinoside (Ara-C), methotrexate, melphalan, 5-fluorouracil (5-FU), and triethylenethiophosphoramide (thiotepa), using rabbit corneal epithelial cell primary tissue cultures. Twenty-four hour [3H]thymidine incorporation was measured 6 hr after the addition of drug or vehicle. A dose-response effect was noted for all agents. Significant (p <0.05) inhibition of thymidine incorporation was reached with Ara-C (10−7M), methotrexate (10−3M), melphalan (10-6M), 5-FU (10−4M), and thiotepa (10−4M). Visual inspection of the cultures was a less sensitive indicator of drug-induced cytotoxicity; except for melphalan, drug concentrations much greater than those that inhibited thymidine incorporation did not alter cell morphology. At a concentration of 10−4M, 2′-deoxycytidine, a competitive inhibitor of Ara-C, protected corneal epithelial cells exposed to Ara-C concentrations up to 10−5M. When used alone, concentrations of deoxycytidine greater than 10−4M were associated with significant impairment of thymidine uptake by cells. This in vitro model may be useful in quantitatively evaluating the epithelial cytotoxicity of other current and future antineoplastic agents, as a means for predicting and possibly moderating corneal toxicity of these agents clinically.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.